Since STD(s) are temperature sensitive as are all single celled organisms, I would recommend in the event of a mutating virus like HIV/AIDS a clinical trial of a thermal shock therapy. You would need an anti coagulant such as saline maintain a low viscosity of the blood, the trick is to nuke the blood just hot enough to maintain the integrity of the blood. Being that all single cell organisms such as viruses have a nucleus (that which controls the functions of the organism [cell brains]) you would have to short or fry the nucleus in effect destroying it's ability to mutate and administer antibiotic treatment. Another thought is to maintain an electrical current through the blood during transfusive loop dialysis. I think it will nullify the HIV cells mutation mechanics within the nucleus and render the virus treatable with antibiotics.
Blood cells are as sensitive to temperature as the viral cells, so a test of the red & white blood cells sensitivity to the treatment would also be required for clinical trials. If sensitivity is antiviral this is an advantage. You can find an intensity to which the virus will be affected and the majority of blood cells will remain functional.
The combination of thermal and electrical charge could possibly burst the virus depending on the effect of the clinical trials. I would call it STD Dialactic Thermal Shock Therapy or SDTS.
The therapy of the blood within the appearance of bed ridden patients contracting MRSA may also have a desired positive effect to weaken the virus to the point of treatable circumstances.
Anybody else over think of things like this?
picture C/o www.tes.com
No comments:
Post a Comment